Latest Breaking News On - Churg strauss syndrome - Page 1 : comparemela.com

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD .

San diegoUnited statesEast sussexUnited kingdomSharon barrLymphopoietin isoformsAmerican lung associationInternational conferenceGlobal initiative on obstructive lung diseaseKyowa kirin co ltdAmerican thoracic society international conferenceGlobal asthma networkBiowa incAmerican partnership for eosinophilic disordersNational heartBlood institute

Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

An international team, including researchers from McMaster University and St. Joseph's Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA).

Freddy hargreaveNader khalidiParameswaran nairFirestone institute for respiratory health at stMcmaster universityMcmaster department of medicineJoe firestone institute for respiratory healthFirestone institute at stHealthcare hamiltonNew england journalFirestone instituteChurg strauss syndromeRespiratory healthAutoimmune diseaseClinical trialGranulomatosis with polyangiitis

Researchers identify new choice of therapy for rare autoimmune disease EGPA

Researchers identify new choice of therapy for rare autoimmune disease EGPA
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Michaele wechslerParameswaran nairFreddy hargreaveNader khalidiMcmaster department of medicineFirestone institute for respiratory health at stFirestone institute at stJoe firestone institute for respiratory healthNew england journalFirestone instituteChurg strauss syndromeRespiratory healthEosinophilic granulomatosis

MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA

MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

District of columbiaUnited statesUnited kingdomJillian gonzalesMichael wechslerSharon barrBrendan mcevoyAmerican academy of allergy asthma immunologyAsthma institute at national jewish healthAmerican partnership for eosinophilic disordersInternational coordinating investigatorBiowa incKyowa kirin co ltdNew england journalAmerican academyAllergy asthma

New Therapy Found for Rare Autoimmune Disease EGPA

New Therapy Found for Rare Autoimmune Disease EGPA
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Nader khalidiFreddy hargreaveParameswaran nairJoe firestone institute for respiratory healthMcmaster department of medicineFirestone institute at stFirestone institute for respiratory health at stMcmaster universityHealthcare hamiltonNew england journalFirestone instituteChurg strauss syndromeRespiratory health